BioSpace News Archive

Data from more than 1,000 patients presented during the virtual 2020 Society for Cardiovascular Angiography & Interventions (SCAI) Scientific Sessions demonstrates Impella reduced in-hospital mortality when placed before a non-emergent percutaneous coronary intervention (PCI) is performed

XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX) (OTCQB: XRTXF) (FRANKFURT: ANU1), a biopharmaceutical company focused on developing innovative therapies to treat kidney disease, is pleased to provide the following update on its clinical stage programs to treat chronic autosomal dominant polycystic kidney disease (ADPKD) - XRx-008 and acute kidney injury (AKI) associated with COVID-19 Infection – XRx-101. XORTX continues to m

Adjuvance Technologies announced today that it has been awarded supplemental contract funding from The National Institute of Allergy and Infectious Diseases (NIAID). The funds will be used to evaluate TQL1055, manufactured by Adjuvance, with SARS-CoV2 antigen, manufactured by NIH (National Institutes of Health). TQL1055 is Adjuvance’s novel Saponin vaccine adjuvant. The total funding in this contract is $1.47million. “

- With an estimated 1 million people in the United States currently living with Parkinson’s, and approximately 60,000 newly diagnosed annually, resources to educate patients and families are critical - Authored by members of the Foundation’s Patient Council, the new guide provides first-hand reflections and practical strategies to answer common questions on understanding and living with Parkinson’s - Anyone touched by Parkinson’s is encouraged to download the free guide at mi

RxMx Corp., a healthcare company with exceptional technology solutions that monitor patient safety, has won the Patient Engagement Innovation award from the Medtech Breakthrough awards for a patient app developed with pharmaceutical company Roche in the area of multiple sclerosis.

PharmaJet ® , the maker of innovative, needle-free injection technology, today announced that its Needle-free Injection System technology will be used to deliver a messenger RNA (mRNA) vaccine against SARS-CoV-2. The vaccine is being developed by Abnova Corporation , the world’s largest antibody manufacturer, based in Taiwan . Abn

First large randomized controlled trial to demonstrate clinically significant and objective benefit from treating the disc, the most common source of back pain Presentation to be part of continuing medical education (CME) event ATLANTA and MIAMI, May 19, 2020 (GLOBE NEWSWIRE) -- VIVEX Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatment options, today announced that results from the company’s VAST study, a 12-month trial

AusculSciences™, a pioneer in developing advanced bioacoustic technologies to detect cardiovascular and pulmonary conditions, today announced that it is developing the Auscul-X™ Touchless Stethoscope System which will allow physicians and nurses to listen to heart and lung sounds at a safe distance from patients with diagnosed or suspected infectious diseases such as COVID-19.

Voltron Therapeutics, Inc. announces today a letter to the shareholders. Dear Voltron Therapeutics shareholders, We hope this letter finds you well during this remarkable time. We would also like to thank for your support of Voltron. The current COVID-19 pandemic is exactly the kind of situation that our VaxCelerate platform was cr

Today, NanoVapor Biotech, a division of NanoVapor Inc., announces a newly formed Executive Advisory team to address innovation in pandemic mitigation using nanotechnology on an industrial scale.